Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV004006218 | SCV004814146 | likely pathogenic | Emery-Dreifuss muscular dystrophy 1, X-linked | 2022-05-11 | criteria provided, single submitter | clinical testing | The EMD c.662_663insT p.(Gln222ProfsTer28) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. This variant occurs in the last exon of the gene and the resulting transcript may escape nonsense-mediated mRNA decay. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant was identified in a de novo state in the proband. Based on the available evidence, the c.662_663insT p.(Gln222ProfsTer28) variant is classified as likely pathogenic for Emery-Dreifuss muscular dystrophy. |